201 related articles for article (PubMed ID: 24486055)
21. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
McCarron PA; Marouf WM; Donnelly RF; Scott C
J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
[TBL] [Abstract][Full Text] [Related]
22. Surface association and uptake of poly(lactic-co-glycolic) acid nanoparticles by Aspergillus flavus.
Muse ES; Patel NR; Astete CE; Damann KE; Sabliov CM
Ther Deliv; 2014 Nov; 5(11):1179-90. PubMed ID: 25491669
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
24. Which skin model is the most appropriate for the investigation of topically applied substances into the hair follicles?
Lademann J; Richter H; Meinke M; Sterry W; Patzelt A
Skin Pharmacol Physiol; 2010; 23(1):47-52. PubMed ID: 20090408
[TBL] [Abstract][Full Text] [Related]
25. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery.
Cai H; Liang Z; Huang W; Wen L; Chen G
Int J Pharm; 2017 Oct; 532(1):55-65. PubMed ID: 28870763
[TBL] [Abstract][Full Text] [Related]
26. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
27. Gradient-dependent release of the model drug TRITC-dextran from FITC-labeled BSA hydrogel nanocarriers in the hair follicles of porcine ear skin.
Tran NBNN; Knorr F; Mak WC; Cheung KY; Richter H; Meinke M; Lademann J; Patzelt A
Eur J Pharm Biopharm; 2017 Jul; 116():12-16. PubMed ID: 27693856
[TBL] [Abstract][Full Text] [Related]
28. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
[TBL] [Abstract][Full Text] [Related]
29. Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles.
Ghotbi Z; Haddadi A; Hamdy S; Hung RW; Samuel J; Lavasanifar A
J Drug Target; 2011 May; 19(4):281-92. PubMed ID: 20590403
[TBL] [Abstract][Full Text] [Related]
30. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
31. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
32. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
33. Penetration of topically applied nanocarriers into the hair follicles of dog and rat dorsal skin and porcine ear skin.
Knorr F; Patzelt A; Darvin ME; Lehr CM; Schäfer U; Gruber AD; Ostrowski A; Lademann J
Vet Dermatol; 2016 Aug; 27(4):256-e60. PubMed ID: 27229377
[TBL] [Abstract][Full Text] [Related]
34. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
35. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats.
Simon LC; Sabliov CM
Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927
[TBL] [Abstract][Full Text] [Related]
36. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
[TBL] [Abstract][Full Text] [Related]
37. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles.
Zhang W; Gao J; Zhu Q; Zhang M; Ding X; Wang X; Hou X; Fan W; Ding B; Wu X; Wang X; Gao S
Int J Pharm; 2010 Dec; 402(1-2):205-12. PubMed ID: 20932886
[TBL] [Abstract][Full Text] [Related]
38. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Radwan MA; Aboul-Enein HY
Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
[TBL] [Abstract][Full Text] [Related]
39. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
[TBL] [Abstract][Full Text] [Related]
40. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
